Delivery Order SPE2DR25D1109-SPE2DR26FFJ3B
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $33K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $38,977.14 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed price contract, which is expected to be completed by August 4, 2025, represents a non-competitive set-aside and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used primarily for weight management in adults with obesity or overweight...
- The Defense Logistics Agency awarded a delivery order valued at $11,074.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on December 4, 2025, with a completion date of December 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used in weight management, reflecting the Defense...
- The Defense Logistics Agency awarded a $6,644.52 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens with a completion date of December 4, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used in diabetes and weight management therapy, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $10,065.66 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on August 29, 2025. This firm fixed price delivery order is non-set-aside and will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with a completion date of September 2, 2025. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the Defense Logistics Agency Medical Supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,741.51 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 25, 2025, with performance taking place at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $28,427.31 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on December 12, 2025, with a completion date of December 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $42,562.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the federal government's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $25,155.58 firm fixed-price delivery order for Zepbound 2.5 mg/0.5 mL pens on December 12, 2025, with an ultimate completion date of December 15, 2025. This contract was competitively awarded with no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,963.10 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on August 7, 2025, with completion expected by August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management and represents part of the...
- The Defense Logistics Agency awarded a delivery order valued at $14,976.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, representing...